Back to results
US 12,060,310 B2Granted
Compositions and methods of using itaconic acid derivatives
AssigneeErgon Pharmaceuticals LLC
InventorAdonia Papathanassiu
Life of this patent
Estimating the term…
Abstract
The present invention is directed to itaconic acid derivatives, compounds comprising the derivatives and methods of using the derivatives in the treatment of cancer, inflammation, and autoimmune diseases.
Claims4
A compound having the following structure:
A compound of Formula (12):
- wherein:
- R21 and R26 are hydrogen
- R16, R17, R19, R20, R22, and R25 are hydrogen,
- R18 is selected from the group consisting of hydrogen, deuterium, C1-C6 alkyl, halo, CN, CF3, —COOH, —OH, C1-C6 alkoxy, —NH2, —(C1-C6 alkyl)NH2, —(C1-C6 alkyl)NH(C1-C6 alkyl), —(C1-C6 alkyl)N(C1-C6 alkyl)2, —NH(C1-C6 alkyl), —N(C1-C6 alkyl)2, —CONH2, —NH(CO)(C1-C6 alkyl), —N(C1-C6 alkyl)CO(C1-C6 alkyl), —SO2—(C1-C6 alkyl), —(SO)NH2, (SO)NH(C1-C6 alkyl), and (SO)N(C1-C6 alkyl)2, and
- R23 and R24 are hydrogen or —CH3.
2 more elements
Dependencies are inferred from the claim text.